Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 5
1964 2
1965 6
1972 1
1974 1
1975 5
1976 1
1977 1
1978 3
1979 7
1980 6
1981 5
1982 5
1983 3
1984 11
1985 7
1986 7
1987 6
1988 16
1989 6
1990 6
1991 6
1992 16
1993 22
1994 22
1995 13
1996 13
1997 14
1998 19
1999 17
2000 28
2001 30
2002 35
2003 15
2004 12
2005 12
2006 14
2007 17
2008 14
2009 4
2010 3
2011 13
2012 29
2013 18
2014 9
2015 8
2016 25
2017 17
2018 12
2019 9
2020 8
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

561 results
Results by year
Filters applied: . Clear all
Page 1
A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.
Tomizawa D, Miyamura T, Imamura T, Watanabe T, Moriya Saito A, Ogawa A, Takahashi Y, Hirayama M, Taki T, Deguchi T, Hori T, Sanada M, Ohmori S, Haba M, Iguchi A, Arakawa Y, Koga Y, Manabe A, Horibe K, Ishii E, Koh K. Tomizawa D, et al. Among authors: ohmori s. Blood. 2020 Oct 15;136(16):1813-1823. doi: 10.1182/blood.2019004741. Blood. 2020. PMID: 32845001
Climber's knuckle excoriation.
Ohmori S, Sawada Y, Nakamura M. Ohmori S, et al. J Dermatol. 2018 Sep;45(9):e264-e265. doi: 10.1111/1346-8138.14301. Epub 2018 Mar 23. J Dermatol. 2018. PMID: 29572907 No abstract available.
In Vitro Inhibitory Effects of Sesamin on CYP4F2 Activity.
Watanabe H, Yamaori S, Kamijo S, Aikawa K, Ohmori S. Watanabe H, et al. Among authors: ohmori s. Biol Pharm Bull. 2020;43(4):688-692. doi: 10.1248/bpb.b19-00953. Biol Pharm Bull. 2020. PMID: 32238710 Free article.
Cryptotia.
Ohmori S, Takada H. Ohmori S, et al. Aesthetic Plast Surg. 1979 Dec;3(1):15-28. doi: 10.1007/BF01577833. Aesthetic Plast Surg. 1979. PMID: 24173970
A Retrospective Study of Superficial Type Atypical Lipomatous Tumor.
Mashima E, Sawada Y, Saito-Sasaki N, Yamamoto K, Ohmori S, Omoto D, Yoshioka H, Yoshioka M, Okada E, Aoki T, Hisaoka M, Nakamura M. Mashima E, et al. Among authors: ohmori s. Front Med (Lausanne). 2020 Dec 17;7:609515. doi: 10.3389/fmed.2020.609515. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33392230 Free PMC article.
Nivolumab in the treatment of malignant melanoma: review of the literature.
Mashima E, Inoue A, Sakuragi Y, Yamaguchi T, Sasaki N, Hara Y, Omoto D, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Nishio D, Nakamura M. Mashima E, et al. Among authors: ohmori s. Onco Targets Ther. 2015 Aug 6;8:2045-51. doi: 10.2147/OTT.S62102. eCollection 2015. Onco Targets Ther. 2015. PMID: 26273207 Free PMC article. Review.
Clinical evidence of pharmacokinetic changes in thalidomide therapy.
Nakamura K, Matsuzawa N, Ohmori S, Ando Y, Yamazaki H, Matsunaga T. Nakamura K, et al. Among authors: ohmori s. Drug Metab Pharmacokinet. 2013;28(1):38-43. doi: 10.2133/dmpk.dmpk-12-rv-089. Epub 2012 Nov 20. Drug Metab Pharmacokinet. 2013. PMID: 23165864 Free article. Review.
561 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page